(1)
Hradyk, T.; Tsysnetska, A. The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients With Type 2 Diabetes Mellitus. APMPLMI 2022, 3, 1-10.